4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-257618
Chief Development Officer sold 20,000 shares at $70.60 ($1,412,000)
- Chief Development Officer acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2026-06-02 | Option exercise 10b5-1 | +20,000 | $21.65 | $433,000 | 23,985 | D: show line 1 in the form |
| Guyer William Chief Development Officer | 2026-06-02 | Sale 10b5-1 | −20,000 | $70.60 | $1,412,000 | 3,985 | D: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $70.60 · $1,412,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2026-06-02 | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 150,000 | D: show line 3 in the form |
Loading xslF345X06/ownership.xml…